Abstract
IntroductionDirect oral anticoagulants (DOACs) have become the anticoagulants of choice for the majority of patients with non-valvular atrial fibrillation (NVAF) and additional risk factors for stroke. The increase in the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
